7 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Clostridium difficile infection ... Episode #Pharmacology ... #Management #CDiff
Antibiotics for Anaerobic Bacteria 
 - Metronidazole (Flagyl™) 
 - Carbapenems 
 - β lactam +
Antibiotics for ... Anaerobic Bacteria ... #Pharmacology # ... Table #Susceptibility ... #Coverage #Management
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... Class Overview ... B for initial management ... - Virtually never ... #Pharmacology #Antibiotics
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... depending on their level ... #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Diagnosis and Management ... polymicrobial infection ... decubitus - air fluid level ... Pathogens: • Aerobic Bacteria ... • Anaerobic Bacteria
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Clostridium difficile infection ... × 10 days #CDiff ... options #treatment #management ... #pharmacology # ... idsa #table
Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Adults
Initial empirical therapy: 
 • Amoxicillin-clavulanate (500 mg/125 mg
PO qd) Severe infection ... Antimicrobial #empiric #idsa ... #antibiotics #Bacterial ... Rhinosinusitis #Adults #management ... #pharmacology